Temporal Dysbiosis of Infant Nasal Microbiota Relative to Respiratory Syncytial Virus Infection

被引:14
|
作者
Grier, Alex [1 ,2 ]
Gill, Ann L. [1 ]
Kessler, Haeja A. [1 ]
Corbett, Anthony [3 ]
Bandyopadhyay, Sanjukta [3 ]
Java, James [3 ]
Holden-Wiltse, Jeanne [3 ]
Falsey, Ann R. [4 ]
Topham, David J. [1 ]
Mariani, Thomas J. [5 ,6 ]
Caserta, Mary T. [7 ]
Walsh, Edward E. [4 ]
Gill, Steven R. [1 ,2 ]
机构
[1] Univ Rochester, Dept Microbiol & Immunol, Sch Med & Dent, 601 Elmwood Ave, Rochester, NY 16462 USA
[2] Univ Rochester, Genom Res Ctr, Sch Med & Dent, Rochester, NY 16462 USA
[3] Univ Rochester, Dept Biostat & Computat Biol, Sch Med & Dent, Rochester, NY 16462 USA
[4] Univ Rochester, Rochester Gen Hosp, Dept Med, Sch Med & Dent, Rochester, NY 16462 USA
[5] Univ Rochester, Div Neonatol, Sch Med & Dent, Rochester, NY 16462 USA
[6] Univ Rochester, Sch Med & Dent, Pediat Mol & Personalized Med Program, Rochester, NY 16462 USA
[7] Univ Rochester, Div Pediat Infect Dis, Sch Med & Dent, Rochester, NY 16462 USA
来源
JOURNAL OF INFECTIOUS DISEASES | 2021年 / 223卷 / 09期
基金
美国国家卫生研究院;
关键词
microbiota; RSV; infant respiratory disease; NASOPHARYNGEAL MICROBIOTA; VIRAL-INFECTIONS; HUMAN RHINOVIRUS; CHILDREN; HEALTH; HOSPITALIZATIONS; GREENGENES; SEVERITY; ASTHMA; RISK;
D O I
10.1093/infdis/jiaa577
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Respiratory syncytial virus (RSV) is a leading cause of infant respiratory disease. Infant airway microbiota has been associated with respiratory disease risk and severity. The extent to which interactions between RSV and microbiota occur in the airway, and their impact on respiratory disease susceptibility and severity, are unknown. Methods. We carried out 16S rRNA microbiota profiling of infants in the first year of life from (1) a cross-sectional cohort of 89 RSV-infected infants sampled during illness and 102 matched healthy controls, and (2) a matched longitudinal cohort of 12 infants who developed RSV infection and 12 who did not, sampled before, during, and after infection. Results. We identified 12 taxa significantly associated with RSV infection. All 12 taxa were differentially abundant during infection, with 8 associated with disease severity. Nasal microbiota composition was more discriminative of healthy vs infected than of disease severity. Conclusions. Our findings elucidate the chronology of nasal microbiota dysbiosis and suggest an altered developmental trajectory associated with RSV infection. Microbial temporal dynamics reveal indicators of disease risk, correlates of illness and severity, and impact of RSV infection on microbiota composition.
引用
收藏
页码:1650 / 1658
页数:9
相关论文
共 50 条
  • [1] Metabolic Reprogramming of Nasal Airway Epithelial Cells Following Infant Respiratory Syncytial Virus Infection
    Connelly, Andrew R.
    Jeong, Brian M.
    Coden, Mackenzie E.
    Cao, Jacob Y.
    Chirkova, Tatiana
    Rosas-Salazar, Christian
    Cephus, Jacqueline-Yvonne
    Anderson, Larry J.
    Newcomb, Dawn C.
    Hartert, Tina, V
    Berdnikovs, Sergejs
    [J]. VIRUSES-BASEL, 2021, 13 (10):
  • [2] Role of nasal microbiota and host response in infants with respiratory syncytial virus infection: Causal questions about respiratory outcomes
    Hasegawa, Kohei
    Carlos, A. Camargo, Jr.
    Mansbach, Jonathan M.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (03) : 898 - 900
  • [3] PATHOGENESIS OF RESPIRATORY SYNCYTIAL VIRUS-INFECTION IN INFANT FERRETS
    PRINCE, GA
    PORTER, DD
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1976, 82 (02): : 339 - 349
  • [4] IMMUNOPROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS-INFECTION IN THE INFANT FERRET
    SUFFIN, SC
    PRINCE, GA
    MUCK, KB
    PORTER, DD
    [J]. JOURNAL OF IMMUNOLOGY, 1979, 123 (01): : 10 - 14
  • [5] Nasal CPAP treatment in an infant with respiratory syncytial virus-associated apnea
    McNamara, F
    Sullivan, CE
    [J]. PEDIATRIC PULMONOLOGY, 1997, 24 (03) : 218 - 221
  • [6] Respiratory Syncytial Virus Infection and the Tight Junctions of Nasal Epithelial Cells
    Tsutsumi, Hiroyuki
    Kojima, Takashi
    Hirakawa, Satoshi
    Masaki, Tomoyuki
    Okabayashi, Tamaki
    Yokota, Shinichi
    Fujii, Nobuhiro
    Himi, Tetsuo
    Sawada, Norimasa
    [J]. RECENT ADVANCES IN TONSILS AND MUCOSAL BARRIERS OF THE UPPER AIRWAYS, 2011, 72 : 153 - 156
  • [7] Nasal and otologic effects of experimental respiratory syncytial virus infection in adults
    Buchman, CA
    Doyle, WJ
    Pilcher, O
    Gentile, DA
    Skoner, DP
    [J]. AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2002, 23 (02) : 70 - 75
  • [8] Nasal mucosal microRNA expression in children with respiratory syncytial virus infection
    Inchley, Christopher S.
    Sonerud, Tonje
    Fjaerli, Hans O.
    Nakstad, Britt
    [J]. BMC INFECTIOUS DISEASES, 2015, 15
  • [9] Nasal mucosal microRNA expression in children with respiratory syncytial virus infection
    Christopher S Inchley
    Tonje Sonerud
    Hans O Fjærli
    Britt Nakstad
    [J]. BMC Infectious Diseases, 15
  • [10] Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection
    Loaiza, Ricardo A.
    Farias, Monica A.
    Andrade, Catalina A.
    Ramirez, Mario A.
    Rodriguez-Guilarte, Linmar
    Munoz, Jose T.
    Gonzalez, Pablo A.
    Bueno, Susan M.
    Kalergis, Alexis M.
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2024,